Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors
PHASE1CompletedINTERVENTIONAL
Enrollment
39
Participants
Timeline
Start Date
July 15, 2015
Primary Completion Date
July 3, 2018
Study Completion Date
October 30, 2018
Conditions
Metastatic Colorectal Cancer
Interventions
DRUG
Irinotecan
Dose Escalation
DRUG
Capecitabine
Dose Escalation
Trial Locations (1)
2730
Herlev Hospital, Herlev
All Listed Sponsors
lead
Dorte Nielsen
OTHER
NCT03295084 - Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors | Biotech Hunter | Biotech Hunter